Revenue: The sum of all revenue fields included for a company's operating activities.
Sanofi (SNY) had Revenue of $13.16B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$13.16B |
$1.89B |
|
$3.67B |
|
$9.49B |
|
$10.72B |
|
$2.44B |
|
$-97.14M |
|
$2.34B |
|
$2.34B |
|
$1.85B |
|
$1.87B |
|
$1.90B |
|
$1.85B |
|
$2.44B |
|
$2.44B |
|
2.41B |
|
2.41B |
|
$0.78 |
|
$0.78 |
|
| Balance Sheet Financials | |
$35.30B |
|
$11.89B |
|
$114.54B |
|
$149.84B |
|
$35.12B |
|
$14.39B |
|
$29.11B |
|
$64.23B |
|
-- |
|
$4.75B |
|
$85.61B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
0.14 |
|
0.25 |
|
72.09% |
|
18.55% |
|
18.55% |
|
-- |
|
17.81% |
|
14.35% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.13 |
|
23.33 |
|
3.86 |
|
-- |
|
39.29% |
|
1.25% |
|
1.87% |
|
-- |
|
-- |
|
-- |
|